S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

SI-Bone Stock Price, Forecast & Analysis (NASDAQ:SIBN)

$17.92
+0.23 (+1.30 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$17.64
Now: $17.92
$18.21
50-Day Range
$15.65
MA: $17.16
$19.76
52-Week Range
$14.08
Now: $17.92
$23.03
Volume97,800 shs
Average Volume121,981 shs
Market Capitalization$440.19 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$55.38 million
Book Value$3.71 per share

Profitability

Net Income$-17,450,000.00

Miscellaneous

Employees183
Market Cap$440.19 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.


SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) posted its quarterly earnings results on Monday, November, 11th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by $0.10. The business earned $16.18 million during the quarter. SI-Bone had a negative net margin of 46.59% and a negative return on equity of 84.84%. View SI-Bone's Earnings History.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for SI-Bone.

What price target have analysts set for SIBN?

0 brokerages have issued 1 year price objectives for SI-Bone's stock. Their forecasts range from $10,000,000.00 to $0.00. On average, they anticipate SI-Bone's stock price to reach $0.00 in the next year. This suggests that the stock has a possible downside of 100.0%. View Analyst Price Targets for SI-Bone.

What is the consensus analysts' recommendation for SI-Bone?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." View Analyst Ratings for SI-Bone.

Has SI-Bone been receiving favorable news coverage?

News headlines about SIBN stock have trended very negative on Wednesday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. SI-Bone earned a news impact score of -3.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for SI-Bone.

Are investors shorting SI-Bone?

SI-Bone saw a decline in short interest during the month of October. As of October 15th, there was short interest totalling 831,400 shares, a decline of 8.3% from the September 15th total of 906,800 shares. Based on an average daily trading volume, of 128,400 shares, the short-interest ratio is currently 6.5 days. Approximately 5.3% of the shares of the stock are sold short. View SI-Bone's Current Options Chain.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-Bone investors own include Home Depot (HD), CVS Health (CVS), Honeywell International (HON), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO), CSX (CSX), Alibaba Group (BABA), Johnson & Johnson (JNJ), Procter & Gamble (PG) and Verizon Communications (VZ).

Who are SI-Bone's key executives?

SI-Bone's management team includes the folowing people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by a number of of institutional and retail investors. Top institutional investors include Commonwealth Equity Services LLC (0.31%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Institutional Ownership Trends for SI-Bone.

Which major investors are selling SI-Bone stock?

SIBN stock was sold by a variety of institutional investors in the last quarter, including Commonwealth Equity Services LLC. Company insiders that have sold SI-Bone company stock in the last year include Anthony J Recupero, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Insider Buying and Selling for SI-Bone.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $17.92.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $440.19 million and generates $55.38 million in revenue each year. The company earns $-17,450,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis. SI-Bone employs 183 workers across the globe.View Additional Information About SI-Bone.

What is SI-Bone's official website?

The official website for SI-Bone is http://si-bone.com/.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]


MarketBeat Community Rating for SI-Bone (NASDAQ SIBN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about SI-Bone and other stocks. Vote "Outperform" if you believe SIBN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIBN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel